Champions Oncology reported the previous year's revenue of 32.12 M. Net Loss for the year was (1.98 M) with profit before overhead, payroll, taxes, and interest of 15.24 M. About 21.0% of the company shares are held by company insiders. Champions Oncology has Price/Earnings (P/E) ratio of 605.0. The entity recorded a loss per share of 0.17. The firm had not issued any dividends in recent years. Champions Oncology had 1:12 split on the 12th of August 2015.